02/02/23 4:05 PMNasdaq : GILD dividendsGilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 DividendGilead Sciences, Inc. today announced that the company’ s Board of Directors has declared an increase of 2.7% in the company’ s quarterly cash dividend, beginning in the first quarter of 2023. The dividend is payable on March 30, 2023, to stockholders of record at the close of business on March 15, 2023. Gilead Sciences, Inc. is a biopharmaceutical company that has...RHEA-AIneutral
02/02/23 4:01 PMNasdaq : GILD earningsGilead Sciences Announces Fourth Quarter and Full Year 2022 Financial ResultsGilead Sciences, Inc. announced today its results of operations for the fourth quarter and full year 2022.. This return to growth was driven by consistent and high quality commercial and clinical execution across our portfolio,” said Gilead’ s Chairman and Chief Executive Officer Daniel O’ Day.“ In HIV, Biktarvy gained market share in the U.S. as it has every quarter...RHEA-AIpositive
02/02/23 9:00 AMNYSE : GILD Gilead Sciences: Toward Health Equity for Black People Impacted by TNBCGilead Sciences Originally Published by Gilead Sciences Racism and the impact of social determinants of health drive disparities in outcomes for Black women impacted by triple-negative breast cancer (TNBC). Addressing these barriers is critical toRHEA-AIneutral
02/01/23 8:35 AMNasdaq : GILD Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast CancerGilead Sciences, Inc. awarded $7.6 million in grant funding to 24 U.S.-based, community organizations through the newly created Toward Health Equity Oncology Grant™. “Gilead is committed to advancing health equity and supporting these vital patient advocacy organizations working to close gaps in breast cancer care,” said Deborah H. Telman, Executive Vice...RHEA-AIpositive
01/30/23 9:00 AMNasdaq : ACLX, GILD Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple MyelomaKite, a Gilead Company, and Arcellx, Inc., today announced the closing of the companies’ previously announced global strategic collaboration to co-develop and co-commercialize Arcellx’ s lead late-stage product candidate, CART-ddBCMA, for the treatment of patients with relapsed or refractory multiple myeloma.RHEA-AIneutral
01/27/23 4:05 PMNasdaq : GILD conferencesGilead Sciences to Present at Upcoming Investor ConferencesGilead Sciences, Inc. announced today that its executives will be speaking at the following investor conferences:. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. For more information on Gilead Sciences, please...RHEA-AIneutral
01/19/23 4:05 PMNasdaq : GILD earningsGilead Sciences to Release Fourth Quarter & Full Year 2022 Financial Results on Thursday, February 2, 2023Gilead Sciences, Inc. announced today that its fourth quarter and full year 2022 financial results and full year 2023 financial guidance will be released on Thursday, February 2 after the market closes. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of...RHEA-AIneutral
01/19/23 9:00 AMNYSE : GILD Decades-Long Effort to Enact Universal HIV Screening for Pregnant Women in IsraelDr. Hila Elinav burst into tears of joy when the Israeli Ministry of Health announced a sweeping new HIV screening policy for pregnant women in September. "It was a long-awaited, emotional moment," says Hila, a member of the Israeli Society for HIVRHEA-AIneutral
01/12/23 9:00 AMNYSE : GILD covid-19Meet Gilead’s COVID-19 Virus Variants HuntersGilead Sciences Every time a serious new COVID-19 virus variant emerges, Gilead virologists Charlotte Hedskog and John Bilello, alongside their teams, mobilize as so-called "variant hunters." Their mission is to determine whether COVID-19RHEA-AIneutral
01/04/23 10:00 AMNYSE : GILD Gilead Sciences: Connecting Breast Cancer Education to Community: Equal HopeGilead Sciences On any given day on the west side of Chicago, you might encounter something unexpected. Outside a retail store or hair salon, there may be a table providing breast cancer education and resources - and it's most likely staffed by EqualRHEA-AInegative